Profile data is unavailable for this security.
About the company
SAPPORO CLINICAL LABORATORY INC. is a Japan-based company mainly engaged in the dispensing pharmacy business. The Company operates in three business segments. The Clinical Examination segment is engaged in the provision of clinical examination needed in medical examinations in hospitals. The Dispensing Pharmacy segment is engaged in operation of dispensing pharmacies, as well as wholesale of drugs and medicines. The Medical Equipment Sale and Maintenance segment is engaged in the sale and maintenance of high level medical equipment, general medical equipment, as well as physics and chemistry equipment. The others business is engaged in the development, sale and maintenance of software for clinical examination system.
- Revenue in JPY (TTM)19.73bn
- Net income in JPY387.40m
- Incorporated1965
- Employees938.00
- LocationSapporo Clinical Laboratory Inc18-2-2, Kitasanjo-Nishi, Chuo-kuSAPPORO-SHI 060-0003JapanJPN
- Phone+81 116416311
- Fax+81 116419802
- Websitehttps://www.saturin.co.jp/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sapporo Clinical Laboratory Inc | 19.73bn | 387.40m | 4.64bn | 938.00 | 9.46 | 0.3378 | 5.20 | 0.235 | 116.33 | 116.33 | 5,924.57 | 3,256.38 | 1.17 | 19.47 | 6.43 | 21,034,420.00 | 2.17 | 5.32 | 2.82 | 6.86 | 30.04 | 31.79 | 1.86 | 3.86 | 1.99 | 287.44 | 0.1688 | 8.71 | 5.33 | 2.88 | -45.48 | -3.66 | 21.19 | 15.90 |
| Sophia Holdings Co Ltd | 9.04bn | 29.33m | 5.00bn | 215.00 | 116.65 | 1.46 | 11.38 | 0.5533 | 9.56 | 9.56 | 3,257.88 | 764.76 | 1.24 | 10.41 | 7.14 | 42,026,600.00 | 0.4016 | 2.38 | 0.6583 | 4.33 | 37.25 | 34.11 | 0.3246 | 1.93 | 1.20 | 13.40 | 0.5324 | 0.00 | -20.04 | 19.85 | -96.56 | -48.30 | 44.35 | -- |
| Pharmarise Holdings Corp | 53.97bn | 302.00m | 7.84bn | 1.56k | 24.36 | 0.9283 | 5.28 | 0.1452 | 26.68 | 26.68 | 4,651.75 | 700.24 | 2.19 | 14.08 | 90.64 | 34,709,970.00 | 1.28 | 1.48 | 2.04 | 2.44 | 15.89 | 15.11 | 0.5855 | 0.6942 | 0.9665 | 36.97 | 0.5705 | 36.13 | 0.8177 | -0.9458 | -25.50 | -- | 6.00 | 0.00 |
| Medical Ikkou Group Co Ltd | 39.90bn | 1.04bn | 10.39bn | 1.30k | 9.23 | 0.7246 | 5.57 | 0.2604 | 276.70 | 276.70 | 10,618.43 | 3,523.26 | 1.35 | 23.72 | 7.22 | -- | 3.66 | 3.11 | 5.39 | 4.52 | 11.41 | 10.52 | 2.71 | 2.55 | 1.44 | -- | 0.409 | 18.01 | 17.71 | 5.03 | 36.89 | 7.88 | -21.67 | 2.38 |
| Satudora Holdings Co Ltd | 94.04bn | 359.00m | 12.56bn | 1.11k | 33.93 | 1.34 | 7.44 | 0.1335 | 26.00 | 26.00 | 6,807.01 | 658.51 | 2.16 | 6.47 | 35.78 | 84,950,320.00 | 0.8468 | 0.6845 | 1.65 | 1.26 | 24.12 | 24.30 | 0.3924 | 0.3045 | 0.4348 | 8.16 | 0.6526 | 57.98 | 5.52 | 2.19 | -72.47 | -10.20 | 3.35 | 1.39 |
| Hyuga Primary Care Co Ltd | 7.83bn | 439.66m | 12.69bn | 442.00 | 29.71 | 8.17 | 21.68 | 1.62 | 58.93 | 58.93 | 1,046.57 | 214.25 | 2.26 | 23.00 | 5.92 | 17,718,790.00 | 12.69 | -- | 25.09 | -- | 22.32 | -- | 5.61 | -- | 1.08 | 177.78 | 0.3316 | -- | 15.13 | -- | 16.57 | -- | -- | -- |
| J Frontier Co Ltd | 17.01bn | -1.71bn | 12.79bn | 255.00 | -- | 4.46 | -- | 0.7518 | -360.79 | -360.79 | 3,528.98 | 558.33 | 2.07 | 6.99 | 9.25 | 66,696,210.00 | -20.89 | -- | -35.65 | -- | 46.62 | -- | -10.10 | -- | 0.9656 | -77.39 | 0.5128 | -- | 41.83 | -- | -574.36 | -- | -- | -- |
| Medical System Network Co Ltd | 113.85bn | 2.11bn | 19.34bn | 3.62k | 9.03 | 1.22 | 3.69 | 0.1698 | 69.85 | 69.85 | 3,772.48 | 515.66 | 1.67 | 10.62 | 32.34 | 31,458,410.00 | 3.12 | 1.77 | 4.83 | 2.72 | 41.74 | 40.13 | 1.86 | 1.10 | 0.6138 | 13.55 | 0.6026 | 28.57 | 2.69 | 3.11 | -32.75 | 9.52 | -17.64 | 3.71 |
Data as of May 02 2024. Currency figures normalised to Sapporo Clinical Laboratory Inc's reporting currency: Japanese Yen JPY
4.14%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Fidelity Management & Research Co. LLCas of 15 Jan 2024 | 154.60k | 3.67% |
| Fidelity Investments Canada ULCas of 31 Mar 2024 | 20.00k | 0.47% |
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
